Breaking Down a Biotech's Assets
110525
A hedge fund thinks Enzon's shares are undervalued, and here's why.
704471
Explore powerful options available to mid-sized companies
285697
Looking at drug R&D is the best way to begin assessing biotech companies.
104872
When Genzyme Inc. breaks down its revenue this year, there's a big hole: treatment of cancer.
632263
Late-stage drugs are crucial for a company beset with patent losses.
226441
Biotechnology companies are betting that pairing old drugs can be a better business than inventing new ones from scratch.
301149
Cambridge Antibody Technology&#39;s (Nasdaq: CATG) legal victory over Abbott Laboratories (NYSE: ABT) shows that a biotech David can triumph over a pharmaceutical Goliath.
304071
Biogen releases its third-quarter financial results.
662923
A major expansion is announced for a biotech company based at a former slate quarry.
466729
Feed this company to your portfolio.
683806
The biotech company reported net income of $833 million, or 71 cents per share, for the latest quarter.
610181
Stock market investors are infamous for their laser focus on immediate results when they put a price on risk and potential reward every day. Unless, of course, they're investing in biotech stocks.
300694
Construction of the third laboratory building in Boston University's BioSquare life sciences research complex is underway, the first such building there to be designed for academic research and commercial businesses. To lure for-profit biotechnology companies, the $53 million, 160,000-square-foot building at 670 Albany St. has a sleek contemporary look, an energy-efficient interior, and a for-profit developer, Spaulding &amp; Slye Colliers.
592179
You don't have to be Google to challenge the way Wall Street manages initial public offerings. A little southwest Virginia biotechnology company has just gone public using the same innovative "open IPO" process as Google.
245176
Cancer was the biotech's biggest success story. Now to keep growing, it needs to branch out.
532856
Diversification means different things to different companies.
320472
Fool Paul Elliott takes a chance on biotech -- with somebody else's money.